Regulations/Policies - Page 2 of 29 - Express Pharma

Pharma and medtech marketing: Navigating the imminent disclosure deadline

7 common compliance issues faced by the pharmaceutical industry in India

US drug pricing order – Implications for India’s pharma sector

CDSCO issues compliance framework for SEZ-to-DTA drug transfers

FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M

CDSCO launches online registration process for CROs

Understanding opportunities and challenges for SMEs after breather on Schedule M deadline

India’s biopharma industry needs to become a little bit more ambitious

Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M

DPDP Rules call for stringent data protection, consent management